1-6 of 465 Activities
This fast-paced and highly interactive livestream CaseWise™ symposium from CME Outfitters will bring real-world clinical decision-making to life. Through dynamic patient cases, learners will compare their treatment choices to those of leading experts, peers in the room, providers in the community, patients themselves, and even AI-based insights. Learners will see how evidence translates into practice, what doesn’t, and why. Designed to challenge assumptions and sharpen strategy, this immersive format empowers clinicians to immediately apply the latest IL-23 inhibitor data, enhance communication and shared decision-making, and deliver truly patient-centered IBD care.
Generalized myasthenia gravis (gMG) disrupts neuromuscular transmission, creating unpredictable symptom flare-ups and placing a significant burden on patients with this rare condition. Most commonly associated with antibodies targeting the acetylcholine receptor (AChR), and less commonly with muscle specific kinase (MuSK) or low-density lipoprotein receptor–related protein 4 (LRP4), gMG has forced patients and clinicians to navigate treatments that can be difficult to tolerate, slow to act, or limited by safety concerns. The expanding availability of neonatal Fc receptor (FcRn) blockers has introduced targeted options designed to reduce pathogenic IgG and improve symptoms. Clinicians, however, lack practical, evidence-based guidance on optimizing FcRn antagonist regimens in partial responders, including interval adjustments, transitions between cyclic and consistent dosing, structured monitoring, and safe steroid tapering, which results in persistent symptoms and avoidable treatment burden. Clinicians and multidisciplinary care teams require rigorous education in optimized dosing and longitudinal management to transform the care experience for patients with gMG.
In the second activity of this CME Outfitters BriefCase series, expert faculty will differentiate MOAs, safety, and efficacy profiles of currently approved FcRn antagonists for the treatment of gMG. Faculty will incorporate strategies to identify patients with gMG who may be appropriate candidates for treatment with FcRn antagonists, and utilize an individualized approach to treatment planning for patients with gMG receiving FcRn antagonists based on the latest data as well as patient preferences.
In the first activity of this CME Outfitters BriefCase series, expert faculty will differentiate MOAs, safety considerations, and efficacy data of currently approved FcRn antagonists for the treatment of gMG. Faculty will incorporate strategies to identify patients with gMG who may be appropriate candidates for FcRn antagonist therapy, and apply an individualized approach to treatment planning based on available evidence and patient preferences.
This fast-paced recorded CaseWise™ symposium from CME Outfitters will bring real-world clinical decision-making to life. Through dynamic patient cases, learners will compare their treatment choices to those of leading experts, peers in the room, providers in the community, patients themselves, and even AI-based insights. Learners will see how evidence translates into practice, what doesn’t, and why. Designed to challenge assumptions and sharpen strategy, this immersive format empowers clinicians to immediately apply the latest IL-23 inhibitor data, enhance communication and shared decision-making, and deliver truly patient-centered IBD care.
In this CME Outfitters Snack, part of a series on health equity, expert faculty will address these gaps by assessing the impact of trauma and ACEs on child and adolescent development, health and behaviors, particularly in diverse patient populations. Faculty will utilize validated age- and setting-appropriate trauma screening and assessment tools within a culturally sensitive framework to address the needs of diverse pediatric populations. Learners will be shown how to develop a trauma-informed implementation plan with team roles, training touchpoints, and process measures and collaboration with community-based resources to mitigate barriers and promote equitable health access in underserved populations.
In this CME Outfitters Snack, part of a series on health equity, expert faculty will identify cross-sector roles guiding care coordination in child and family health including integration with schools, welfare agencies, and community partners. Faculty will differentiate the unique assessment and support needs for children and adolescents with developmental disabilities including roles of coordinated services, culturally sensitive care, and shared decision-making. Learners will be guided through employing evidence-based strategies to address continuity of care during the transition from child and adolescent care to adult care across the fields of medical, behavioral, legal, and education/vocation services, particularly with patients with complex needs. Lastly, faculty will implement culturally sensitive coordination practices with tribal nations and Indigenous communities that honor sovereignty, promote trust, and uphold best practices aligned with ICWA in cross-sector partnerships.
In this third installment of a CME Outfitters Snack Series, expert faculty will evaluate clinically supported risk stratification tools and clinical indicators to identify hospitalized patients more accurately with SARS-CoV-2 infection who are at increased risk for progression to severe disease.
